Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Poliomyelitis Drugs in Development Market Report Overview
Polio is a highly infectious disease caused by a virus. It invades the nervous system and causes total paralysis in hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio.
The Poliomyelitis drugs in development market research report provides comprehensive information on the Poliomyelitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Poliomyelitis targeted therapeutics development with respective active and dormant or discontinued projects.
| Key Target | · Diphtheria Toxin
· Pertussis Toxin · Tetanus Toxin · Haemophilus influenzae Lipooligosaccharide · Toll Like Receptor 5 |
| Key Mechanism of Action | · Toll Like Receptor 5 Agonist |
| Key Routes of Administration | · Intramuscular Oral
· Subcutaneous · Intradermal · Intravenous, Parenteral · Transdermal |
| Key Molecule Types | · Inactivated Vaccine
· Live Attenuated Vaccine · Toxoid Vaccine · Subunit Vaccine · Conjugate Vaccine · Vaccine |
| Leading Companies | · Biological E Ltd
· KM Biologics Co Ltd · Beijing Minhai Biotechnology Co Ltd · LG Chem Ltd · Panacea Biotec Ltd · Serum Institute of India Pvt Ltd |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Poliomyelitis Drugs in Development Market - Competitive Landscape
A few of the leading companies in the Poliomyelitis drugs in development market are Biological E Ltd, KM Biologics Co Ltd, Beijing Minhai Biotechnology Co Ltd, LG Chem Ltd, Panacea Biotec Ltd, and Serum Institute of India Pvt Ltd among others.
Biological Mimetics Inc (BMI): Biological Mimetics Inc (BMI) is a developer and commercializer of human and veterinary biologics to address hitherto intractable disease targets including viruses, bacteria, parasites, and cancer. The company offers vaccines and monoclonal antibodies for therapeutic, diagnostic and research purposes.
Poliomyelitis Drugs in Development Market Analysis, by Companies, 2022(%)
Buy the Full Report for More Competitor Insights on the Poliomyelitis Drugs in Development Market, Download a Free Report Sample
Poliomyelitis Drugs in Development Market Segmentation by Target
The key targets in the Poliomyelitis drugs in development market are Diphtheria Toxin, Pertussis Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Toll Like Receptor 5. Diphtheria Toxin, Pertussis Toxin, and Tetanus Toxin accounted for the highest number of Poliomyelitis Drugs in Development in development in 2022.
Buy the Full Report for More Target Insights on the Poliomyelitis Drugs in Development Market, Download a Free Report Sample
Poliomyelitis Drugs in Development Market Segmentation by Mechanism of Action
The key mechanism of action of the Poliomyelitis drugs in development market is Toll Like Receptor 5 Agonist.
Poliomyelitis Drugs in Development Market Segmentation by Routes of Administration
The key routes of administration in the Poliomyelitis drugs in development market are intramuscular, oral, subcutaneous, intradermal, intravenous, parenteral, and transdermal. Intramuscular is the most preferred RoA in the Poliomyelitis drugs in development market in 2022.
Poliomyelitis Drugs in Development Market Analysis, by Routes of Administration, 2022(%)
Buy the Full Report for More RoA Insights on the Poliomyelitis Drugs in Development Market, Download a Free Report Sample
Poliomyelitis Drugs in Development Market Segmentation by Molecule Types
A few of the key molecule types in the Poliomyelitis drugs in development market are inactivated vaccine, live attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and vaccine. Inactivated vaccine led the Poliomyelitis Drugs in Development market in terms of molecule types.
Poliomyelitis Drugs in Development Market Analysis, by Molecule Types, 2022(%)
Buy the Full Report for More Molecule Type Insights on the Poliomyelitis Drugs in Development Market, Download a Free Report Sample
Poliomyelitis Drugs in Development – Featured News and Press Releases
- On 9th June 2022, Sinovac Biotech receives WHO prequalification for polio vaccine.
- On 12th April 2022, Pertussis, Diphtheria, Tetanus, Polio, Hib vaccine filed in Japan: BIKEN/Mitsubishi
Buy the Full Report for More Featured News and Press Insights on the Poliomyelitis Drugs in Development Market, Download a Free Report Sample
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Poliomyelitis (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Poliomyelitis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Poliomyelitis (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Poliomyelitis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Poliomyelitis (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Poliomyelitis (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Poliomyelitis (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Beijing Tiantan Biological Products Co Ltd
Bharat Biotech Ltd
Biken Co Ltd
Biological E Ltd
Biological Mimetics Inc
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Grifols SA
Helix Biogen Institute
Intravacc BV
Johnson & Johnson
KM Biologics Co Ltd
LG Chem Ltd
Micron Biomedical Inc
Nanolek
Panacea Biotec Ltd
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Statera Biopharma Inc
Vaxxas Inc
Wuhan Institute of Biological Products Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key target areas in the Poliomyelitis drugs in development market?
The key targets in the Poliomyelitis drugs in development market are Diphtheria Toxin, Pertussis Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Toll Like Receptor 5.
-
What are the key mechanisms of action in the Poliomyelitis drugs in development market?
The key MoA in the Poliomyelitis drugs in development market is Toll Like Receptor 5 Agonist.
-
What are the key routes of administration in the Poliomyelitis drugs in development market?
The key RoA in the Poliomyelitis drugs in development market are intramuscular oral, subcutaneous, intradermal, intravenous, parenteral, and transdermal.
-
What are the key molecule types in the Poliomyelitis drugs in development market?
The key molecule types in the Poliomyelitis drugs in development market are inactivated vaccine, live attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and vaccine.
-
Which are the leading companies in the Poliomyelitis drugs in development market?
A few of the leading companies in the Poliomyelitis drugs in development market are Biological E Ltd, KM Biologics Co Ltd, Beijing Minhai Biotechnology Co Ltd, LG Chem Ltd, Panacea Biotec Ltd, and Serum Institute of India Pvt Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Infectious Disease reports